{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:31:20Z","timestamp":1762176680221,"version":"3.40.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jim.2013.11.005","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T09:00:38Z","timestamp":1385024438000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes"],"prefix":"10.1016","volume":"402","author":[{"given":"Tinashe B.","family":"Ruwona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Mcbride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Chappel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Head","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Ordoukhanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-9864","authenticated-orcid":false,"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansun","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2013.11.005_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/bc0001239","article-title":"A chemoselective method for site-specific immobilization of peptides via aminooxy group","volume":"12","author":"Adamczyk","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jim.2013.11.005_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-59745-372-1_8","article-title":"Peptide microarrays for serum antibody diagnostics","volume":"509","author":"Andresen","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jim.2013.11.005_bb0015","doi-asserted-by":"crossref","first-page":"17033","DOI":"10.1073\/pnas.0407902101","article-title":"Printed covalent glycan array for ligand profiling of diverse glycan binding proteins","volume":"101","author":"Blixt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0020","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2013.11.005_bb0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bioeng.2006.02.001","article-title":"Protein and peptide arrays: recent trends and new directions","volume":"23","author":"Cretich","year":"2006","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.jim.2013.11.005_bb0035","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1073\/pnas.1305306110","article-title":"Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus","volume":"110","author":"Deng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0040","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/JVI.68.10.6147-6160.1994","article-title":"Formation and intracellular-localization of hepatitis-C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses","volume":"68","author":"Dubuisson","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2013.11.005_bb0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1515\/znc-2003-7-819","article-title":"Increased resistance of peptides to serum proteases by modification of their amino groups","volume":"58","author":"Galati","year":"2003","journal-title":"Z. Naturforsch. C."},{"key":"10.1016\/j.jim.2013.11.005_bb0050","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"2012, human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0055","doi-asserted-by":"crossref","first-page":"e1002653","DOI":"10.1371\/journal.ppat.1002653","article-title":"Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate","volume":"8","author":"Keck","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jim.2013.11.005_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2144\/000113810","article-title":"Increased affinity and solubility of peptides used for direct peptide ELISA on polystyrene surfaces through fusion with a polystyrene-binding peptide tag","volume":"52","author":"Kogot","year":"2012","journal-title":"BioTechniques"},{"key":"10.1016\/j.jim.2013.11.005_bb0065","doi-asserted-by":"crossref","first-page":"13085","DOI":"10.1128\/JVI.01939-12","article-title":"Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33","volume":"86","author":"Kong","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2013.11.005_bb0070","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.1202924109","article-title":"Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1","volume":"109","author":"Kong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-59745-394-3_4","article-title":"Nomenclature and numbering of the hepatitis C virus","volume":"510","author":"Kuiken","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jim.2013.11.005_bb0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/hep.21377","article-title":"A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes","volume":"44","author":"Kuiken","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jim.2013.11.005_bb0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.vaccine.2005.08.096","article-title":"Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry","volume":"24","author":"Lees","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl.","key":"10.1016\/j.jim.2013.11.005_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1037","article-title":"Protein microarrays and proteomics","volume":"32","author":"MacBeath","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jim.2013.11.005_bb0095","first-page":"11","article-title":"Confirmation of HCV antibodies by the line immunoassay INNO-LIA HCV Ab III","volume":"19","author":"Maertens","year":"1999","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.jim.2013.11.005_bb0100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2013.11.005_bb0105","doi-asserted-by":"crossref","first-page":"e23699","DOI":"10.1371\/journal.pone.0023699","article-title":"A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection","volume":"6","author":"Meyer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2013.11.005_bb0110","doi-asserted-by":"crossref","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jim.2013.11.005_bb0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-1759(95)00053-D","article-title":"Grafting peptides onto polystyrene microplates for ELISA","volume":"182","author":"Niveleau","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2013.11.005_bb0120","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jim.2013.11.005_bb0125","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1128\/JVI.02052-12","article-title":"Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody","volume":"86","author":"Potter","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2013.11.005_bb0130","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/655902","article-title":"Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins","volume":"202","author":"Ray","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2013.11.005_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0958-1669(02)00339-7","article-title":"Peptide arrays: from macro to micro","volume":"13","author":"Reimer","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jim.2013.11.005_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(02)00139-4","article-title":"Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences","volume":"267","author":"Reineke","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2013.11.005_bb0145","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1073\/pnas.93.5.1759","article-title":"A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells","volume":"93","author":"Rosa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.270.5235.467","article-title":"Quantitative monitoring of gene expression patterns with a complementary DNA microarray","volume":"270","author":"Schena","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jim.2013.11.005_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-1759(96)00173-1","article-title":"Preferential labeling of alpha-amino N-terminal groups in peptides by biotin, application to the detection of specific anti-peptide antibodies by enzyme immunoassays","volume":"199","author":"Selo","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2013.11.005_bb0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2013.11.005_bb0165","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jim.2013.11.005_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2144\/04373RR01","article-title":"Producing peptide arrays for epitope mapping by intein-mediated protein ligation","volume":"37","author":"Sun","year":"2004","journal-title":"BioTechniques"},{"key":"10.1016\/j.jim.2013.11.005_bb0175","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1128\/JVI.06492-11","article-title":"Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization","volume":"86","author":"Tarr","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2013.11.005_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/viro.2002.1463","article-title":"Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding","volume":"298","author":"Triyatni","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jim.2013.11.005_bb0185","doi-asserted-by":"crossref","first-page":"20125","DOI":"10.1073\/pnas.1117531108","article-title":"Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV\/HIV chimeric virus infected macaque","volume":"108","author":"Walker","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0190","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1073\/pnas.89.8.3468","article-title":"Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections","volume":"89","author":"Weiner","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0195","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/pr060217d","article-title":"Comparison of hydroxylated print additives on antibody microarray performance","volume":"5","author":"Wu","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jim.2013.11.005_bb0200","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.0902749106","article-title":"Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2013.11.005_bb0205","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.1128\/JVI.01426-12","article-title":"Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors","volume":"86","author":"Zhu","year":"2012","journal-title":"J. Virol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175913002986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175913002986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:08:17Z","timestamp":1597050497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175913002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022175913002986"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2013.11.005","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2013.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}